Do Pneumococcal Conjugate Vaccines Represent Good Value for Money in a Lower-Middle Income Country? A Cost-Utility Analysis in the Philippines

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.09.1549
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost-Utility Analysis of 10- And 13-Valent Pneumocococcal Conjugate Vaccines in the Philippines

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Cost-Utility Analysis of 10- And 13-Valent Pneumococcal Conjugate Vaccines: Protection at What Price in the Thai Context?

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2013English

Cost-Effectiveness Analysis of Pneumococcal Conjugate Vaccines in Preventing Pneumonia in Peruvian Children

Journal of Infection in Developing Countries
MedicineVirologyParasitologyInfectious DiseasesMicrobiology
2014English

Pin62 - Cost-Effectiveness of Pneumococcal Conjugate Vaccines in a Cohort of Newborns in Colombia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pneumococcal Conjugate Vaccines in Different Settings

The Lancet Infectious Diseases
Infectious Diseases
2019English

Pneumococcal Conjugate Vaccines: New Hope for Infancy

Revista Chilena de Infectologia
EnvironmentalPublic HealthInfectious DiseasesOccupational Health
2001English

Pneumococcal Conjugate Vaccines in Different Settings – Authors' Reply

The Lancet Infectious Diseases
Infectious Diseases
2019English

The Potential Impact and Cost-Effectiveness of Current and Future Pneumococcal Conjugate Vaccines in India

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Vaccines for Children in Low- And Middle-Income Countries

2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy